Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Recurrence 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1

Interventions

Cisplatin 3Radiotherapy, Intensity-Modulated 2Radiotherapy 2Paclitaxel 2temoporfin 1pyrotinib 1fluoromisonidazole 1bicalutamide 1Rubidium-82 1Ritonavir 1Radiotherapy, Conformal 1Nivolumab 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Leuprolide 1Ipilimumab 1Indinavir 1Gemcitabine 1Fluorodeoxyglucose F18 1Enzyme-Linked Immunosorbent Assay 1Docetaxel 1Chemotherapy, Adjuvant 1Carboplatin 1CTLA-4 Antigen 1Brachytherapy 1Amifostine 15-fluoropentyl-2-methylmalonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Salivary Gland Neoplasms × temoporfin × Clear all
NCT00003856 2013-12-19

Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
75 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡